Elaine Sun
Net worth: 561 602 $ as of 30/09/2026
Net worth: 561 602 $ as of 30/09/2026
Elaine D. Sun occupies the position of Chief Financial Officer & Senior Vice President at Halozyme Therapeutics, Inc. Ms. Sun is also on the board of Cirius Therapeutics, Inc. In the past Ms. Sun was Chief Financial & Strategy Officer at Vaxcyte, Inc., Managing Director at Merrill Lynch & Co., Inc. and Managing Director at Evercore Capital Partners. She received an undergraduate degree from Wellesley College and an MBA from Harvard Business School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/06/2026 | 1,35,981 ( 0.03% ) | 561 602 $ | 30/09/2026 |
| Companies | Position | Start |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Director/Board Member | 15/03/2025 |
Mammoth Biosciences, Inc.
Mammoth Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops CRISPR-based genetic medicines, diagnostics, genome-editing technologies for healthcare and life science applications | Director of Finance/CFO | 23/03/2022 |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Director/Board Member | 05/01/2023 |
| Companies | Position | End |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Director/Board Member | 10/02/2026 |
| HALOZYME THERAPEUTICS, INC. | Director of Finance/CFO | 02/02/2022 |
| VAXCYTE, INC. | Director of Finance/CFO | 01/12/2019 |
Nobel Laureate Meetings Lindau
Nobel Laureate Meetings Lindau Miscellaneous Commercial ServicesCommercial Services Operate as an internationally renowned scientific forum and academic cultural foundation | Founder | - |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that develops therapies | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Dynavax Technologies Corp.
Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Wellesley College
Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evercore Capital Partners
Evercore Capital Partners Investment ManagersFinance Evercore Capital invests in middle-market companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for growth stage capital requirements. | Finance |
Nobel Laureate Meetings Lindau
Nobel Laureate Meetings Lindau Miscellaneous Commercial ServicesCommercial Services Operate as an internationally renowned scientific forum and academic cultural foundation | Commercial Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that develops therapies | Health Technology |
Mammoth Biosciences, Inc.
Mammoth Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops CRISPR-based genetic medicines, diagnostics, genome-editing technologies for healthcare and life science applications | Commercial Services |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions